Oligomer-protein tyrosine kinase inhibitor conjugates
Abstract:
The invention relates to (among other things) oligomer-PTK inhibitor conjugates and related compounds. A compound of the invention, when administered by any of a number of administration routes, exhibits advantages over PTK inhibitor compounds lacking a water-soluble, non-peptidic oligomer.
Public/Granted literature
Information query
Patent Agency Ranking
0/0